Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Bronchial Hyperreactivity

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Bronchial Hyperreactivity in 4 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koarai, A1
Ichinose, M1
Sugiura, H1
Yamagata, S1
Hattori, T1
Shirato, K1
Muijsers, RB1
van Ark, I1
Folkerts, G1
Koster, AS1
van Oosterhout, AJ1
Postma, DS1
Nijkamp, FP1
Que, LG1
Liu, L1
Yan, Y1
Whitehead, GS1
Gavett, SH1
Schwartz, DA1
Stamler, JS1
Komlósi, ZI1
Pozsonyi, E1
Tábi, T1
Szöko, E1
Nagy, A1
Bartos, B1
Kozma, GT1
Tamási, L1
Orosz, M1
Magyar, P1
Losonczy, G1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge[NCT03926741]Early Phase 160 participants (Anticipated)Interventional2019-04-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Bronchial Hyperreactivity

ArticleYear
Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice.
    Pulmonary pharmacology & therapeutics, 2000, Volume: 13, Issue:6

    Topics: Amidines; Animals; Benzylamines; Blotting, Western; Bronchial Hyperreactivity; Enzyme Inhibitors; Eo

2000
Apocynin and 1400 W prevents airway hyperresponsiveness during allergic reactions in mice.
    British journal of pharmacology, 2001, Volume: 134, Issue:2

    Topics: Acetophenones; Amidines; Animals; Antioxidants; Benzylamines; Bronchial Hyperreactivity; Bronchoalve

2001
Protection from experimental asthma by an endogenous bronchodilator.
    Science (New York, N.Y.), 2005, Jun-10, Volume: 308, Issue:5728

    Topics: Adrenergic beta-Agonists; Alcohol Dehydrogenase; Allergens; Animals; Asthma; Bronchi; Bronchial Hype

2005
Lipopolysaccharide exposure makes allergic airway inflammation and hyper-responsiveness less responsive to dexamethasone and inhibition of iNOS.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:7

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Cytokines; Dexamethasone; Drug Resistance; Female; Gluco

2006